GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Schrodinger Inc (NAS:SDGR) » Definitions » Change In Receivables
中文

Schrodinger (Schrodinger) Change In Receivables : $-20.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Schrodinger Change In Receivables?

Schrodinger's change in receivables for the quarter that ended in Dec. 2023 was $-57.0 Mil. It means Schrodinger's Accounts Receivable increased by $57.0 Mil from Sep. 2023 to Dec. 2023 .

Schrodinger's change in receivables for the fiscal year that ended in Dec. 2023 was $-20.0 Mil. It means Schrodinger's Accounts Receivable increased by $20.0 Mil from Dec. 2022 to Dec. 2023 .

Schrodinger's Accounts Receivable for the quarter that ended in Dec. 2023 was $66.0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Schrodinger's Days Sales Outstanding for the three months ended in Dec. 2023 was 81.24.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Schrodinger's liquidation value for the three months ended in Dec. 2023 was $258.1 Mil.


Schrodinger Change In Receivables Historical Data

The historical data trend for Schrodinger's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schrodinger Change In Receivables Chart

Schrodinger Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial -6.59 -9.28 -5.51 -27.95 -20.03

Schrodinger Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.35 8.93 35.93 -7.90 -56.98

Schrodinger Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-20.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Schrodinger  (NAS:SDGR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Schrodinger's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=65.992/74.126*91
=81.24

2. In Ben Graham's calculation of liquidation value, Schrodinger's accounts receivable are only considered to be worth 75% of book value:

Schrodinger's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=463.003-254.397+0.75 * 65.992+0.5 * 0
=258.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Schrodinger Change In Receivables Related Terms

Thank you for viewing the detailed overview of Schrodinger's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Schrodinger (Schrodinger) Business Description

Traded in Other Exchanges
Address
1540 Broadway, 24th Floor, New York, NY, USA, 10036
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
Executives
Kenneth Patrick Lorton officer: See Remarks SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK NY 10036
Margaret Dugan officer: Chief Medical Officer C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVE, CAMANA BAY, PO BOX 1348, GRAND CAYMAN E9 KY1-1108
Yvonne Tran officer: See Remarks SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK NY 10036
Nancy Thornberry director SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK NY 10036
Ramy Farid director, 10 percent owner, officer: See Remarks SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK NY 10036
Geoffrey Craig Porges officer: EVP & CFO 1540 BROADWAY, 24TH FL., NEW YORK NY 10036
Arun Oberoi director 100 EAST DAVIE STREET, RALEIGH NC 27601
Robert Lorne Abel officer: See Remarks SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK NY 10036
Karen Akinsanya officer: See Remarks SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK NY 10036
Joel Lebowitz officer: See Remarks SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK NY 10036
David E Shaw 10 percent owner 120 WEST FORTY-FIFTH STREET, 39TH FLOOR, NEW YORK NY 10036
Jorg Weiser officer: See Remarks SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK NY 10036
Jennifer Daniel officer: See Remarks SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK NY 10036
D'cruz Cony officer: See Remarks SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK NY 10036
Richard Friesner director, 10 percent owner SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK NY 10036